Role of neuroinflammation in hypertension-induced brain amyloid pathology

Neurobiology of Aging

Volumn 33, Issue 1, 2012, Pages 205.e19-205.e29

  Carnevale, Daniela ^a   Mascio, Giada ^a   Ajmone Cat, Maria Antonietta ^b   D'Andrea, Ivana ^b   Cifelli, Giuseppe ^a   Madonna, Michele ^a   Cocozza, Germana ^a   Frati, Alessandro ^a   Carullo, Pierluigi ^a   Carnevale, Lorenzo ^a   Alleva, Enrico ^b   Branchi, Igor ^b   Lembo, Giuseppe ^a,c   Minghetti, Luisa ^b  

^a IRCCS NEUROMED   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Alzheimer's disease; Cerebral hemodynamics; Glial cells; Hypertension; Inflammation

Indexed keywords

AMYLOID BETA PROTEIN; IBUPROFEN; INTERLEUKIN 1BETA;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA COARCTATION; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; ENZYME REGULATION; GENE SEQUENCE; HYPERTENSION; IMMUNOSTIMULATION; MALE; MICROGLIA; MOUSE; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 81355135325     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2010.08.013     Document Type: Article

References (28)

1. Bailey T.L., Rivara C.B., Rocher A.B., Hof P.R. The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease. Neurol. Res 2004, 26:573-578.
2. Brancaccio M., Fratta L., Notte A., Hirsch E., Poulet R., Guazzone S., De Acetis M., Vecchione C., Marino G., Altruda F., Silengo L., Tarone G., Lembo G. Melusin, a muscle-specific integrin beta1-interacting protein, is required to prevent cardiac failure in response to chronic pressure overload. Nat. Med 2003, 9:68-75.
3. Combrinck M.I., Perry V.H., Cunningham C. Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease. Neuroscience 2002, 12:7-11.
4. de La Torre J.C. Alzheimer disease as a vascular disorder: nosological evidence. Stroke 2003, 33:1152-1162.
5. DiCarlo G., Wilcock D., Henderson D., Gordon M., Morgan D. Intrahippocampal LPS injections reduce Abeta load in APP+PS1 transgenic mice. Neurobiol. Aging 2001, 22:1007-1012.
6. Fotuhi M., Hachinski V., Whitehouse P.J. Changing perspectives regarding late-life dementia. Nat. Rev. Neurol 2009, 5:649-658.
7. Gentile M.T., Poulet R., Di Pardo A., Cifelli G., Maffei A., Vecchione C., Passarelli F., Landolfi A., Carullo P., Lembo G. Beta-amyloid deposition in brain is enhanced in mouse models of arterial hypertension. Neurobiol. Aging 2009, 30:222-228.
8. Hainsworth A.H., Markus H.S. Do in vivo experimental models reflect human cerebral small vessel disease?. A systematic review. J. Cereb. Blood Flow Metab 2008, 28:1877-1891.
9. Iadecola C., Davisson R.L. Hypertension and cerebrovascular dysfunction. Cell Metab 2008, 7:476-484.
10. Li J.J., Chen J.L. Inflammation may be a bridge connecting hypertension and atherosclerosis. Med. Hypotheses 2005, 64:925-929.
11. McGeer P.L., McGeer E.G. NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies. Neurobiol. Aging 2007, 28:639-647.
12. McKee A.C., Carreras I., Hossain L., Ryu H., Klein W.L., Oddo S., LaFerla F.M., Jenkins B.G., Kowall N.W., Dedeoglu A. Ibuprofen reduces Abeta, hyperphosphorylated tau and memory deficits in Alzheimer mice. Brain Res 2008, 1207:225-236.
13. Minghetti L. Role of inflammation in neurodegenerative diseases. Curr. Opin. Neurol 2005, 18:315-321.
14. Minghetti L., Greco A., Cardone F., Puopolo M., Ladogana A., Almonti S., Cunningham C., Perry V.H., Pocchiari M., Levi G. Increased brain synthesis of prostaglandin E2 and F2-isoprostane in human and experimental transmissible spongiform encephalopathies. J. Neuropathol. Exp. Neurol 2000, 59:866-871.
15. Mrak R.E., Griffin W.S. Glia and their cytokines in progression of neurodegeneration. Neurobiol. Aging 2005, 26:349-354.
16. Palin K., Cunningham C., Forse P., Perry V.H., Platt N. Systemic inflammation switches the inflammatory cytokine profile in CNS Wallerian degeneration. Neurobiol. Dis 2008, 30:19-29.
17. Perry V.H., Cunningham C., Holmes C. Systemic infections and inflammation affect chronic neurodegeneration. Nat. Rev. Immunol 2007, 7:161-167.
18. Sheng J.G., Bora S.H., Xu G., Borchelt D.R., Price D.L., Koliatsos V.E. Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice. Neurobiol. Dis 2003, 14:133-145.
19. Skoog I., Gustafson D. Update on hypertension and Alzheimer's Disease. Neurol. Res 2006, 28:605-611.
20. Strle K., Zhou J.H., Shen W.H., Broussard S.R., Johnson R.W., Freund G.G., Dantzer R., Kelley K.W. Interleukin-10 in the brain. Crit. Rev. Immunol 2001, 21:427-449.
21. Town T., Laouar Y., Pittenger C., Mori T., Szekely C.A., Tan J., Duman R.S., Flavell R.A. Blocking TGFbeta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology. Nat. Med 2008, 14:681-687.
22. Tsukuda K., Mogi M., Iwanami J., Min L.J., Sakata A., Jing F., Iwai M., Horiuchi M. Cognitive Deficit in Amyloid-{beta}-Injected Mice Was Improved by Pretreatment With a Low Dose of Telmisartan Partly Because of Peroxisome Proliferator-Activated Receptor-{gamma} Activation. Hypertension 2009, 54:782-787.
23. Varvel N.H., Bhaskar K., Kounnas M.Z., Wagner S.L., Yang Y., Lamb B.T., Herrup K. NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease. J. Clin. Invest 2009, 119:3692-3702.
24. Wang J., Ho L., Chen L., Zhao Z., Zhao W., Qian X., Humala N., Seror I., Bartholomew S., Rosendorff C., Pasinetti G.M. Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease. J. Clin. Invest 2007, 117:3393-3402.
25. Wu Z., Guo H., Chow N., Sallstrom J., Bell R.D., Deane R., Brooks A.I., Kanagala S., Rubio A., Sagare A., Liu D., Li F., Armstrong D., Gasiewicz T., Zidovetzki R., Song X., Hofman F., Zlokovic B.V. Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease. Nat. Med 2005, 11:959-965.
26. Wyss-Coray T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response?. Nat. Med 2006, 12:1005-1015.
27. Yong V.W., Rivest S. Taking advantage of the systemic immune system to cure brain diseases. Neuron 2009, 15:55-60.
28. Zlokovic B.V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008, 57:178-201.